High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme

Bone Marrow Transplant. 1996 Sep:18 Suppl 1:S69-72.

Authors

C Linassier¹, L Benboubker, S Velut, G Calais, D Saudeau, M Jan, A Autret, C Berger, P Biron, P Colombat

Affiliation

¹ Chu Bretonneau, Tours, France.

PMID: 8899180

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase II

MeSH terms

Adult
Aged
Antineoplastic Agents, Alkylating / administration & dosage*
Bone Marrow Transplantation*
Carmustine / administration & dosage*
Combined Modality Therapy
Female
Glioblastoma / drug therapy
Glioblastoma / radiotherapy
Glioblastoma / therapy*
Humans
Male
Middle Aged
Supratentorial Neoplasms / drug therapy
Supratentorial Neoplasms / radiotherapy
Supratentorial Neoplasms / therapy*
Transplantation, Autologous

Substances

Antineoplastic Agents, Alkylating
Carmustine